RUBRA MEDICAMENTS LTD. - 531099 - Fixes Book Closure for AGM
Rubra Medicaments Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 24, 2019 to September 26, 2019 (both days inclusive) for the purpose of 28th Annual General Meeting (AGM) of the Company to be held on September 30, 2019. Rubra Medicaments Ltd - 531099 - Outcome of Board Meeting (AGM on Sept 30, 2019)
Rubra Medicaments Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 09, 2019, inter alia, has considered and approved the following:- 28th Annual General Meeting scheduled to be held on September 30, 2019. Rubra Medicaments Ltd - 531099 - Unaudited Financial Result For The Quarter Ended June 30, 2019 Alongwith Limited Review Report
Unaudited financial Result for the quarter ended June 30, 2019 alongwith Limited Review Report Rubra Medicaments Ltd - 531099 - Board Meeting Intimation for Unaudited Financial Result For The Quarter Ended June 30, 2019
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve Unaudited Financial Result for the quarter ended June 30, 2019 Rubra Medicaments Ltd - 531099 - Shareholding for the Period Ended June 30, 2019
Rubra Medicaments Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here Rubra Medicaments Ltd - 531099 - Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Abha KapoorDesignation :- Director RUBRA MEDICAMENTS LTD. - 531099 - Announcement under Regulation 30 (LODR)-Cessation
Resignation of Company Secretary Rubra Medicaments Ltd - 531099 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of SEBI (LODR), 2015 For The Year Ended March 31, 2019
Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (LODR), 2015 for the year ended March 31, 2019 RUBRA MEDICAMENTS LTD. - 531099 - Outcome of Board Meeting
Submission of ''Declaration on the Independent Auditors Report with unmodified opinion'' for the year ended March 31, 2019 Rubra Medicaments Ltd - 531099 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Shifting of Registered office of the Company from the State of Telangana to the State of Maharashtra and consequential amendment to the domicile clause in the Memorandum of Association and intimation of new CIN of the Company.